A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea

BACKGROUND: There are few pharmacologic options to reduce erythema and flushing in patients with recalcitrant erythematotelangiectatic rosacea (ETR). We previously reported two cases of refractory flushing and erythema of rosacea that were successfully treated with intradermal botulinum toxin inject...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kui Young, Kwon, Hyun Jung, Kim, Jae Min, Jeong, Guk Jin, Kim, Beom Joon, Seo, Seong Jun, Kim, Myeong Nam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992459/
https://www.ncbi.nlm.nih.gov/pubmed/33911508
http://dx.doi.org/10.5021/ad.2018.30.6.688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992459/
https://www.ncbi.nlm.nih.gov/pubmed/33911508
http://dx.doi.org/10.5021/ad.2018.30.6.688

Ejemplares similares